Latest News
PathAI Acquires Laboratory Operator Poplar Healthcare Management
Tuesday 27 July 2021

US-based pathology research tools and services provider PathAI has acquired Poplar, the management service organization for anatomic pathology laboratory services provider Poplar Healthcare PLLC, the company said.

Memphis-based Poplar Healthcare supports physicians across the country with its GI Pathology, D-PATH Dermatology, OncoMetrix, Bostwick Laboratories and Women's Health Laboratories specialized testing services.

Poplar's facilities, management team and 350 employees now comprise PathAI's diagnostics division, which will remain based in Memphis.

Together, PathAI and Poplar will be investing to further digitize the Poplar laboratory workflow, and leverage PathAI's image analysis and algorithm development capabilities to unlock new clinical applications.

In partnering with Poplar Healthcare, PathAI adds traditional laboratory services at scale to its already powerful suite of AI-powered pathology tools.

Combining the companies' complementary expertise provides PathAI with end-to-end capabilities to support the development and delivery of new and distinctive AI-driven products for drug development and for patient care.

The transaction follows the close of PathAI's Series C Financing of USD 165m co-led by D1 Capital Partners and Kaiser Permanente.

The round included existing lead investors General Atlantic and General Catalyst as well as strategic partners Bristol-Myers Squibb Company (NYSE: BMY) and Merck Global Health Innovation Fund.

Founded in 1995 and headquartered in Memphis, Poplar Healthcare is an anatomic laboratory services company that provides specialized laboratory testing services to a nationwide client base of gastroenterologists, dermatologists, oncologists, urologists, gynecologists and their patients.

PathAI is a provider of AI-powered research tools and services for pathology. PathAI's platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning.

Based in Boston, PathAI works with life sciences companies and researchers to advance precision medicine.
Date Published: 27/07/2021